- About BME
- Academics Home
- Combined Degrees
- Student Resources
- Industry Home
- Partner Benefits
- Student Design Projects
- Guest Lectures
- BME Interns
- Research Collaborations
- Tech Licensing
- Industry News
- "Women's Radio Network Open Forum" To Feature AxoGen, Inc.
- 3rd Annual Pruitt Research Day
- AxoGen, Inc. Announces Clearance from FDA to Proceed with New Multicenter Comparative Study for Avance® Nerve Graft
- AxoGen, Inc. Announces Completion of a Pilot Clinical Study Assessing Cavernous Nerve Reconstruction with Avance® Nerve Graft
- BioD LLC Makes $1 Million Gift Commitment to UF BME
- BioD Receives U.S. Patent for Unique Placental Tissue Technology
- Dr. Peter McFetridge awarded the Tim Brahm Professorship
- Event Celebrates BioD’s $1 Million Gift to BME
- New Industry Partner: Sigma Aldrich Corporation
- RTI Surgical™ Announces Agreement With Novation
- Record BME Industry Partner Participation at the 4th Annual Pruitt Research Day
- SPECIAL EVENT: “Geraldo Rivera Show” to Feature AxoGen, Inc.
- Stryker Provides Guest Lecture to BME Students
- Contact Us
Dobson elected as Fellow of the American Institute for Medical and Biological Engineering (AIMBE)
January 22, 2015
Congratulations to Dr. Jon Dobson who was elected as a Fellow of the American Institute for Medical and Biological Engineering (AIMBE). This is a distinct honor that is awarded to the upper 2% of all bioengineers who have excelled in the biomedical and biological engineering fields.
AIMBE is the authoritative voice and advocate for the value of medical and biological engineering to society. New AIMBE Fellows are elected by about 1,200 AIMBE Fellows; the elected Fellows have to be voted in by at least 75% of the voting members. The new Fellows' induction to AIMBE will take place in the National Academy of Sciences building in Washington DC on March 16, 2015, during AIMBE’s annual event.
Dobson was elected for outstanding contributions to the development of magnetic micro- and nanoparticle-based technologies in cell engineering, regenerative medicine and gene transfection. His research focuses on biomedical applications of magnetic nanoparticles. His group has developed novel technologies for (i) magnetic targeting and remote activation of cell signaling pathways for cell engineering and regenerative medicine; (ii) magnetic nanoparticle-based gene transfection; and (iii) magnetic targeting of modified cell carriers. He also leads a multi-national research program developing novel imaging and characterization techniques to quantify, characterize and map iron compounds related to neurodegenerative diseases.
Congratulations, Dr. Dobson!